BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190624
DTEND;VALUE=DATE:20190627
DTSTAMP:20260514T232713
CREATED:20190326T120821Z
LAST-MODIFIED:20190326T121125Z
UID:20086-1561334400-1561593599@www.pharmajournalist.com
SUMMARY:GI Inflammatory Diseases Summit (GIIDS)
DESCRIPTION:Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases \nThe GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease. \nIncorporating insights from leading pharma and pioneering biotech\, this discussion and networking forum will curate the cutting edge insights on: \n\nImproving drug safety profiles of more gut-selective compounds\nOptimizing trial design in a hypercompetitive market\nThe promise of microbiome based biotherapeutics\n\nJoin gastroenterology\, immunology and anti-inflammatory drug developers at this unique conference and push the clinical frontier nearer to achieving significant clinical remission in larger groups of patients.
URL:https://www.pharmajournalist.com/event/gi-inflammatory-diseases-summit-giids/
LOCATION:Revere Hotel Boston Common  200 Stuart Street  Boston\, MA\, 02116  USA\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260514T232713
CREATED:20190418T090640Z
LAST-MODIFIED:20190418T090640Z
UID:20372-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:2nd Combination Products Lifecycle Management Summit
DESCRIPTION:Returning to Boston for its 2nd successful year in 2019\, the CPLM Summit features a fresh speaker line-up including the FDA\, Alnylam\, kaleo\, Novartis and many others\, as well as a pre-conference focus day to give you a comprehensive LCM guide to your combination products. \n \nLifecycle management for drug-device combination product has stolen the spotlight amongst pharma\, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is a lot of potential and many benefits to having such a mind-set and implementing a robust LCM program from the get-go. \nAs the only peer-led community\, we will bring in 100+ senior leaders from drug-device teams including the regulatory affairs\, product development and quality to share their view and encourage collaborative efforts. \nFor more information on 2nd Annual CPLM Summit\, visit https://ter.li/11hr26
URL:https://www.pharmajournalist.com/event/2nd-annual-cplm-summit/
LOCATION:Hyatt Regency Boston\, One Ave. de Lafayette\, Boston\, MA\, 02111\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260514T232713
CREATED:20190426T082151Z
LAST-MODIFIED:20190426T082638Z
UID:20510-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:Cell Engager Summit
DESCRIPTION:The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic. \n \nOvercome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug. \nDiscover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies. \nWith 22+ hours of content\, 2 interactive workshops and over 5 hours of networking with key industry leaders\, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges. \nJoin us as we unite experts from across large pharma\, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies. \nTo learn more and to register online\, visit cell-engager-summit.com
URL:https://www.pharmajournalist.com/event/cell-engager-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR